BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1812578)

  • 1. [Human immunodeficiency virus infection in hemophiliacs: prevalence and current clinical situation].
    Lorenzo JI; Molina R; Arilla MJ; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1991 Dec; 36(6):451-5. PubMed ID: 1812578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
    Brenner B; Schwartz S; Ben-Porath E; Tatarsky I; Varon D; Martinowitz U
    Isr J Med Sci; 1991 Oct; 27(10):557-61. PubMed ID: 1955309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progression of HIV infection in a cohort of hemophiliacs over an 11-year period].
    Altisent Roca C; Ayestarán Altuna A; Tusell Puigbert JM; Oliveras Martín J; Montoro Ronsano JB; Vila Baucells M
    Med Clin (Barc); 1995 Mar; 104(11):411-4. PubMed ID: 7715259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
    Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
    Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
    Astermark J; Berntorp E; Stigendal L; Johnsson H
    Lakartidningen; 1998 Jan; 95(1-2):48-50. PubMed ID: 9458646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
    Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
    Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of hepatitis A virus in Japanese haemophiliacs.
    Hayashi K; Fukuda Y; Nakano I; Katano Y; Nagano K; Yokozaki S; Hayakawa T; Toyoda H; Takamatsu J
    J Infect; 2001 Jan; 42(1):57-60. PubMed ID: 11243755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of four Chinese hemophiliacs with human immunodeficiency virus infection.
    Tang DJ; Xu YH; Dai D; Han YJ; Wang BC; Lang YM; Liang Y; Zeng Y
    Chin Med J (Engl); 1989 Nov; 102(11):819-24. PubMed ID: 2517721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
    Goldsmith JM; Deutsche J; Tang M; Green D
    Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-epidemiological patterns of HIV infection in STD patients in Ibadan.
    Ekweozor CC; Olaleye OD; Tomori O; Saliu I; Essien EM; Bakare RA; Oni AA; Oyewo OO; Okesola AO; Onyemenem TN
    Afr J Med Med Sci; 1995 Dec; 24(4):321-7. PubMed ID: 8886145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM; van der Meer J; Smit JW; Halie MR
    Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
    Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
    J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk of acquired immune deficiency syndrome (AIDS) and of AIDS related complex (ARC) in hemophiliacs seropositive for more than 5 years.
    Stain C; Pabinger-Fasching I; Guggenberger K; Köller U; Stain M; Hartl H; Heinz F; Mayerhofer S; Kyrle PA; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):354-6. PubMed ID: 2799750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
    Meili EO
    Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic investigation of Chinese hemophiliacs with and without human immunodeficiency virus infection.
    Tang DJ; Pang XG
    Chin Med J (Engl); 1991 Oct; 104(10):803-7. PubMed ID: 1752140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
    Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.